SCHEMBL30443655

SCHEMBL30443655

CC(C)c1ncncc1B1OC(C)(C)C(C)(C)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25211100 1.00 — —
SCHEMBL22445287 0.85 AAK1 (0.32) —
SCHEMBL900563 0.77 LPL (0.31) —
SCHEMBL30881090 0.76 DGAT1 (0.33) —
SCHEMBL29691149 0.75 LPL (0.36) —
SCHEMBL18865597 0.75 LPL (0.36) —
SCHEMBL18865569 0.74 LPL (0.36) —
SCHEMBL18794947 0.73 LPL (0.33) —
SCHEMBL15535670 0.73 EGFR (0.33) —
SCHEMBL31482498 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4430050-A1 SMALL MOLECULE INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 1 (USP1) AND USES THEREOF Insilico Medicine IP Limited (HK) 2024-09-18 — — EP disclosed
EP-4271676-A1 CARBONYL SUBSTITUTED DIAZASPIRO COMPOUNDS AND ITS USE Bionova Pharmaceuticals (Shanghai) Limited (CN) 2023-11-08 — — EP disclosed
WO-2023083286-A1 SMALL MOLECULE INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 1 (USP1) AND USES THEREOF INSILICO MEDICINE IP LIMITED (CN) 2023-05-19 — — WO disclosed
Send feedback